Mesoblast (MESO) EBIT Growth (1y) (2015 - 2023)
Mesoblast (MESO) EBIT Growth (1y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 14,015.31% |
| Mar 31, 2023 | 64.55% |
| Dec 31, 2022 | 55.83% |
| Sep 30, 2022 | 33.28% |
| Jun 30, 2022 | 100.42% |
| Mar 31, 2022 | 62.95% |
| Dec 31, 2021 | -45.23% |
| Sep 30, 2021 | 13.03% |
| Jun 30, 2021 | -105.36% |
| Mar 31, 2021 | -68.06% |
| Dec 31, 2020 | 7.00% |
| Sep 30, 2020 | -456.08% |
| Jun 30, 2020 | 58.51% |
| Mar 31, 2020 | 43.88% |
| Dec 31, 2019 | 22.38% |
| Sep 30, 2019 | 83.21% |
| Jun 30, 2019 | -17.47% |
| Mar 31, 2019 | 3.82% |
| Dec 31, 2018 | -210.77% |
| Sep 30, 2018 | -130.46% |